471946860	471946860	CD	B-NP	O
|	|	NN	I-NP	O
DCH	DCH	NN	I-NP	O
|	|	NN	I-NP	O
90313239	90313239	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3807465	3807465	CD	B-NP	O
|	|	CC	I-NP	O
10/23/2006	10/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/6/2006	1/6/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/13/2006	6/13/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
MAGLIOLO	MAGLIOLO	NNP	B-NP	O
,	,	,	O	O
REGINALD	REGINALD	NNP	B-NP	O
003-80-70-1	003-80-70-1	CD	I-NP	O
Smouth	Smouth	NNP	I-NP	O
Greenstaer	Greenstaer	NNP	I-NP	O
Green	Green	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
M	M	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/5/06	2/5/06	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FERGOSON	FERGOSON	NNP	B-NP	O
,	,	,	O	O
CLAYTON	CLAYTON	NNP	B-NP	O
H.	H.	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
SWIGER	SWIGER	NN	B-NP	O
,	,	,	O	O
DONNY	DONNY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
786341538	786341538	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	NNS	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
POST-MI	POST-MI	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
SLAGOWSKI	SLAGOWSKI	NN	B-NP	O
,	,	,	O	O
EARLE	EARLE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
786341538	786341538	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	NNS	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
15	15	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
LEZER	LEZER	NN	B-NP	B-protein
,	,	,	O	O
CORNELIUS	CORNELIUS	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
223718137	223718137	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	NNS	B-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
500	500	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/5	10/5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

SPIRONOLACTONE	SPIRONOLACTONE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
by	by	IN	B-PP	O
MENCHU	MENCHU	NNP	B-NP	O
,	,	,	O	O
CHANG	CHANG	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	NNS	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	JJ	B-NP	O
home	home	NN	I-NP	O
medicatin	medicatin	NN	I-NP	O
NEXIUM	NEXIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	B-protein
DR	DR	NN	I-NP	I-protein
JAMAL	JAMAL	NNP	I-NP	O
GERMAN	GERMAN	NNP	I-NP	O
MORBER	MORBER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
251	251	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
026-9596	026-9596	CD	I-NP	O
8/19/06	8/19/06	CD	I-NP	O
@	@	SYM	B-NP	O
3	3	CD	I-NP	O
:	:	SYM	I-NP	O
50	50	CD	I-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
CARD	CARD	NNP	B-NP	O
DR	DR	NNP	I-NP	O
RITZIE	RITZIE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
051377-9954	051377-9954	CD	I-NP	O
4/7/06	4/7/06	CD	I-NP	O
@	@	SYM	B-NP	O
1	1	CD	I-NP	O
:	:	SYM	I-NP	O
00	00	CD	I-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
CARD	CARD	NNP	B-NP	O
DR	DR	NNP	I-NP	O
BUCKELEW	BUCKELEW	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
389	389	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
710-9257	710-9257	CD	I-NP	O
CLINIC	CLINIC	NN	I-NP	O
WILL	WILL	NN	I-NP	O
CONTACT	CONTACT	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
percoumadinclinic	percoumadinclinic	NN	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
KMMC	KMMC	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
STEMI	STEMI	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
LV	LV	NN	I-NP	O
mural	mural	NN	I-NP	O
thrombus	thrombus	IN	B-PP	O
1/13	1/13	CD	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
IDENTIFICATION	IDENTIFICATION	NN	B-NP	O
:	:	:	O	O
73F	73F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
recent	recent	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
STEMI	STEMI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
9/22	9/22	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
c/b	c/b	NN	I-NP	O
apical	apical	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
most	most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
EF	EF	NN	I-NP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
admitted	admit	VBN	B-VP	O
from	from	IN	B-PP	O
home	home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
increasing	increase	VBG	B-VP	O
DOE	DOE	NN	B-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Chepiga	Chepiga	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
lovely	lovely	JJ	I-NP	O
73yo	73yo	CD	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
in	in	IN	B-PP	O
9/22	9/22	CD	B-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
STEMI	STEMI	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
DES	DES	NNP	B-NP	O
to	to	TO	B-PP	O
ramus	ramus	NN	B-NP	O
and	and	CC	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Flow	Flow	NN	B-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
TIMI	TIMI	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Course	Course	NN	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
post-MI	post-MI	JJ	B-NP	O
pericarditis	pericarditis	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
wall	wall	NN	I-NP	O
thinning	thinning	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mural	mural	JJ	B-NP	O
LV	LV	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
to	to	TO	B-PP	O
short-term	short-term	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
subsequently	subsequently	RB	B-VP	O
went	go	VBD	I-VP	O
home	home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
weekly	weekly	NN	I-NP	O
f/u	f/u	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
cardiac	cardiac	JJ	I-NP	O
rehab	rehab	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
at	at	IN	B-PP	O
short	short	JJ	B-NP	O
term	term	NN	I-NP	O
rehab	rehab	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
b/c	b/c	NN	I-NP	O
of	of	IN	B-PP	O
``	``	``	O	O
dizzy	dizzy	JJ	B-NP	O
spells	spell	NNS	I-NP	O
''	''	''	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
experiencing	experience	VBG	I-VP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
off	off	IN	B-PP	O
lasix	lasix	CD	B-NP	O
until	until	IN	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
fatigue	fatigue	NN	I-NP	O
at	at	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
says	say	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	B-ADVP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
for	for	IN	B-PP	O
15	15	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
treadmill	treadmill	NN	I-NP	O
;	;	:	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
n't	n't	RB	I-VP	O
been	be	VBN	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
this	this	DT	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
b/c	b/c	NN	I-NP	O
of	of	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
PND	PND	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
occurring	occur	VBG	B-VP	O
as	as	RB	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
as	as	IN	B-PP	O
3-5	3-5	CD	B-NP	O
times/night	times/night	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
pound	pound	NN	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
increasing	increase	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
acknowledge	acknowledge	VB	I-VP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
this	this	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
can	can	NN	I-NP	O
of	of	IN	B-PP	O
mushroom	mushroom	NN	B-NP	B-protein
soup	soup	NN	I-NP	I-protein
4	4	CD	B-NP	I-protein
days	day	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	I-protein
-RRB-	-RRB-	NNP	B-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

Mrs.	Mrs.	NNP	B-NP	O
Bloxsom	Bloxsom	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
rehab	rehab	NN	I-NP	O
.	.	.	O	O

contacted	contact	VBD	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Takach	Takach	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
to	to	TO	B-VP	O
inform	inform	VB	I-VP	O
her	her	PRP	B-NP	O
about	about	IN	B-PP	O
Mrs.	Mrs.	NNP	B-NP	O
Losey	Losey	NNP	I-NP	O
DOE	DOE	NNP	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

Starting	Start	VBG	B-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
then	then	RB	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
taken	take	VBN	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
urgent	urgent	JJ	B-NP	O
care	care	NN	I-NP	O
this	this	DT	B-NP	O
PM	PM	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
desat	desat	VB	I-VP	O
.	.	.	O	O

to	to	TO	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ambulation	ambulation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

STEMI	STEMI	NN	B-NP	B-protein
,	,	,	O	O
9/22	9/22	CD	B-NP	O
s/p	s/p	NN	I-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
DESx2	DESx2	NN	I-NP	O
c/b	c/b	NN	I-NP	O
apical	apical	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
thrombus	thrombus	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
latest	late	JJS	I-NP	O
EF	EF	NN	I-NP	B-protein
35	35	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Dyslipidemia	Dyslipidemia	NN	B-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
HOME	HOME	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Metformin	Metformin	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
bid	bid	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
qdaily	qdaily	RB	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-NP	O
qdaily	qdaily	RB	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-NP	O
qdaily	qdaily	RB	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	RB	B-NP	I-protein
qdaily	qdaily	RB	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Tramadol	Tramadol	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
6H	6H	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
lantus	lantus	NN	I-NP	I-protein
23	23	CD	I-NP	I-protein
U	U	NN	I-NP	I-protein
sc	sc	NN	I-NP	I-protein
qAM	qAM	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
aspart	aspart	RB	B-NP	O
8	8	CD	I-NP	O
U	U	NN	I-NP	O
sc	sc	NN	I-NP	O
qAC	qAC	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
aspart	aspart	RB	B-VP	O
sliding	slide	VBG	I-VP	O
scale	scale	NN	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qAM	qAM	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
13	13	CD	B-NP	O
.	.	.	O	O

Spironolactone	Spironolactone	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	RB	B-ADVP	I-protein
qdaily	qdaily	RB	B-NP	I-protein
14	14	CD	I-NP	I-protein
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	B-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qdaily	qdaily	RB	B-ADVP	O
SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Lives	Live	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
.	.	.	O	O

Distant	Distant	JJ	B-NP	O
and	and	CC	I-NP	O
minimal	minimal	JJ	I-NP	O
5-6	5-6	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
quit	quit	VBD	B-VP	O
~	~	NN	B-NP	B-protein
12	12	CD	B-NP	I-protein
years	year	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	I-protein
-RRB-	-RRB-	NNP	B-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
Tc	Tc	NN	I-NP	O
98	98	CD	I-NP	O
;	;	:	O	O
P	P	NN	B-NP	B-protein
88	88	CD	I-NP	I-protein
;	;	:	O	O
BP	BP	NN	B-NP	O
136/84	136/84	CD	I-NP	O
;	;	:	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RA	RA	NN	B-NP	B-protein
NAD	NAD	NN	I-NP	I-protein
,	,	,	O	O
well-appearing	well-appearing	JJ	B-NP	O
JVP	JVP	NN	I-NP	O
~	~	NN	I-NP	O
8	8	CD	I-NP	O
cm	cm	NN	I-NP	O
CTAB	CTAB	NN	I-NP	O
PMI	PMI	NN	I-NP	O
laterally	laterally	RB	B-ADVP	O
displaced	displace	VBD	B-VP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
normal	normal	JJ	I-NP	O
intensity	intensity	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rubs	rub	NNS	I-NP	O
,	,	,	O	O
murmurs	murmur	NNS	B-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
.	.	.	O	O

ND/NT	ND/NT	NN	B-NP	O
.	.	.	O	O

WWP	WWP	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
AT	AT	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Na	Na	NN	B-NP	O
+	+	SYM	O	O
144	144	CD	B-NP	O
;	;	:	O	O
K	K	NN	B-NP	O
+	+	SYM	B-ADJP	O
4.1	4.1	CD	B-NP	O
;	;	:	O	O
Cl	Cl	NN	B-NP	O
-	-	:	O	O
105	105	CD	B-NP	O
;	;	:	O	O
CO2	CO2	NN	B-NP	O
31	31	CD	I-NP	O
;	;	:	O	O
BUN	BUN	NN	B-NP	O
20	20	CD	I-NP	O
;	;	:	O	O
creatinine	creatinine	NN	B-NP	O
1.0	1.0	CD	I-NP	O
;	;	:	O	O
glucose	glucose	NN	B-NP	O
73	73	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	O
40	40	CD	I-NP	O
;	;	:	O	O
AST	AST	NN	B-NP	O
27	27	CD	I-NP	O
;	;	:	O	O
ALK	ALK	NN	B-NP	O
61	61	CD	I-NP	O
;	;	:	O	O
TB	TB	NN	B-NP	O
0.4	0.4	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
117	117	CD	I-NP	O
;	;	:	O	O
CKMB	CKMB	NN	B-NP	B-protein
1.6	1.6	CD	I-NP	I-protein
;	;	:	O	O
troponin	troponin	NN	B-NP	O
<	<	SYM	O	O
assay	assay	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Ca2	Ca2	NN	B-NP	B-protein
+	+	SYM	O	O
9.7	9.7	CD	B-NP	O
;	;	:	O	O
Mg2	Mg2	NN	B-NP	O
+	+	SYM	O	O
1.6	1.6	CD	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
6.62	6.62	CD	I-NP	O
;	;	:	O	O
Hct	Hct	NN	B-NP	O
35.9	35.9	CD	I-NP	O
;	;	:	O	O
PLT	PLT	NN	B-NP	O
213	213	CD	I-NP	O
RELEVANT	RELEVANT	NN	I-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
.	.	.	O	O

Q	Q	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	O
;	;	:	O	O
along	along	IN	B-PP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
V1-V4	V1-V4	NN	I-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
Mild	Mild	NNP	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
7/5/2006	7/5/2006	CD	I-NP	O
ECHO	ECHO	NN	I-NP	O
:	:	:	O	O
Mildly	Mildly	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
systolic	systolic	JJ	I-NP	O
diameter	diameter	NN	I-NP	O
:	:	:	O	O
3.57	3.57	CD	B-NP	O
cm	cm	NN	I-NP	O
and	and	CC	O	O
diastolic	diastolic	JJ	B-NP	O
diameter	diameter	NN	I-NP	O
:	:	:	O	O
5.89	5.89	CD	B-NP	O
cm	cm	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
function	function	NN	I-NP	O
moderately	moderately	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
EF	EF	NN	I-NP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Anteroseptal	Anteroseptal	JJ	B-NP	O
wall	wall	NN	I-NP	O
is	be	VBZ	B-VP	O
akinetic	akinetic	JJ	B-ADJP	O
from	from	IN	B-PP	O
midventricular	midventricular	JJ	B-NP	O
level	level	NN	I-NP	O
to	to	TO	B-PP	O
apex	apex	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hypokinetic	hypokinetic	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Focal	Focal	JJ	B-NP	O
basal	basal	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
new	new	JJ	B-ADJP	O
from	from	IN	B-PP	O
7/5/05	7/5/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
is	be	VBZ	B-VP	O
focally	focally	RB	B-ADJP	O
aneurismal	aneurismal	JJ	I-ADJP	O
.	.	.	O	O

False	False	JJ	B-NP	O
tendon	tendon	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

Global	Global	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
mildly	mildly	RB	B-VP	O
reduced	reduce	VBN	I-VP	O
.	.	.	O	O

Trace	Trace	NNP	B-NP	O
TR	TR	NNP	I-NP	O
.	.	.	O	O

Trace	Trace	NNP	B-NP	O
TR	TR	NNP	I-NP	O
.	.	.	O	O

PASP	PASP	NN	B-NP	O
17	17	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
+	+	SYM	B-NP	O
RAP	RAP	NN	I-NP	B-protein
.	.	.	O	O

11/26	11/26	CD	B-NP	O
ETT	ETT	NNP	I-NP	O
:	:	:	O	O
Duration	Duration	NN	B-NP	O
3	3	CD	I-NP	O
'	'	SYM	I-NP	O
20	20	CD	I-NP	O
''	''	''	O	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
d/t	d/t	NN	B-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

Attained	Attain	VBN	B-VP	O
4.7	4.7	CD	B-NP	O
METS	METS	NNS	I-NP	O
.	.	.	O	O

Maximum	Maximum	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
125	125	CD	I-NP	O
at	at	IN	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

Maximal	Maximal	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
130/70	130/70	CD	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
accentuation	accentuation	NN	B-NP	O
of	of	IN	B-PP	O
baseline	baseline	NN	B-NP	O
ST	ST	NN	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Apparently	Apparently	RB	B-ADVP	O
,	,	,	O	O
low	low	JJ	B-NP	O
HR	HR	NN	I-NP	O
recovery	recovery	NN	I-NP	O
.	.	.	O	O

Imaging	Image	VBG	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
large	large	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
scar	scar	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

Small	Small	JJ	B-NP	O
and	and	CC	I-NP	O
mild	mild	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
territory	territory	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
small	small	JJ	I-NP	O
defect	defect	NN	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
inferolateral	inferolateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Post-stress	Post-stress	NN	B-NP	O
EF	EF	NN	I-NP	O
31	31	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

OVERALL	OVERALL	NN	B-NP	O
ASSESSMENT	ASSESSMENT	NN	I-NP	O
:	:	:	O	O
73F	73F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
recent	recent	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
STEMI	STEMI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
9/22	9/22	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
c/b	c/b	NN	I-NP	O
apical	apical	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
most	most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
EF	EF	NN	I-NP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
admitted	admit	VBN	B-VP	O
from	from	IN	B-PP	O
home	home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
increasing	increase	VBG	B-VP	O
DOE	DOE	NN	B-NP	O
and	and	CC	I-NP	O
new-onset	new-onset	JJ	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

Appears	Appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
fluid	fluid	JJ	B-ADJP	O
overloaded	overload	VBN	B-VP	O
,	,	,	O	O
improved	improve	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
diuresis	diuresis	NN	I-NP	O
over	over	IN	B-PP	O
3	3	CD	B-NP	O
day	day	NN	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CARDS	CARDS	NN	B-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
Volume	Volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
ischemic	ischemic	JJ	I-NP	O
CMP	CMP	NN	I-NP	O
implicated	implicate	VBN	B-VP	O
.	.	.	O	O

Initially	Initially	RB	B-NP	O
received	receive	VBN	I-NP	O
IV	IV	CD	I-NP	O
diuresis	diuresis	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
lasix	lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
bid	bid	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
~	~	VBG	I-VP	O
2.5	2.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

SBP	SBP	NN	B-NP	B-protein
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
following	follow	VBG	B-PP	O
overdiuresis	overdiuresis	NN	B-NP	O
on	on	IN	B-PP	O
6/14	6/14	CD	B-NP	O
held	hold	VBN	I-NP	O
diuresis	diuresis	NN	I-NP	O
on	on	IN	B-PP	O
10/7	10/7	CD	B-NP	O
.	.	.	O	O

Resumed	Resume	VBN	B-NP	O
oral	oral	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
lasix	lasix	CD	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
on	on	IN	B-PP	O
10/5	10/5	CD	B-NP	O
.	.	.	O	O

Discharged	Discharge	VBN	B-VP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
spironolactone	spironolactone	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
to	to	TO	B-VP	O
optimize	optimize	VB	I-VP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
;	;	:	O	O
changed	change	VBD	B-VP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
on	on	IN	B-PP	O
10/7	10/7	CD	B-NP	O
after	after	IN	B-SBAR	O
SBP	SBP	NN	B-NP	B-protein
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
10/7	10/7	CD	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
apparently	apparently	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
this	this	DT	B-NP	O
inconsistently	inconsistently	RB	B-ADVP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CARDS	CARDS	NN	B-NP	O
ISCHEMIA	ISCHEMIA	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
ETT	ETT	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
small	small	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
defect	defect	NN	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
inferolateral	inferolateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CARDS	CARDS	NNP	B-NP	O
RHYTHM	RHYTHM	NNP	I-NP	O
:	:	:	O	O
W	W	NNP	B-NP	O
/	/	SYM	B-NP	O
known	known	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
EF	EF	NN	B-NP	B-protein
~	~	NN	I-NP	I-protein
35	35	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
31	31	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
post-stress	post-stress	JJ	B-NP	O
by	by	IN	B-PP	O
MIBI	MIBI	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
inclined	incline	VBN	B-VP	O
for	for	IN	B-PP	O
AICD	AICD	NN	B-NP	O
placement	placement	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MADIT	MADIT	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Discussed	Discuss	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
EP	EP	NN	I-NP	B-protein
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Pippens	Pippens	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NNP	B-NP	O
Echo	Echo	NNP	I-NP	O
4/3/06	4/3/06	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
estimated	estimate	VBN	I-NP	O
EF	EF	NN	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Defer	Defer	NN	B-NP	O
decision	decision	NN	I-NP	O
on	on	IN	B-PP	O
EP	EP	NN	B-NP	O
eval	eval	NN	I-NP	O
to	to	TO	B-PP	O
primary	primary	JJ	B-NP	B-protein
cardiologist	cardiologist	NN	I-NP	I-protein
Dr.	Dr.	NNP	I-NP	I-protein
Dewolf	Dewolf	NNP	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
Hypoxia	Hypoxia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Weaned	Wean	VBN	B-NP	O
O2	O2	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
adequate	adequate	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
9/22	9/22	CD	B-NP	O
course	course	NN	I-NP	O
c/b	c/b	NN	I-NP	O
LV	LV	NN	I-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
echo	echo	NN	I-NP	O
.	.	.	O	O

w/o	w/o	NN	B-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
apex	apex	NN	I-NP	O
quite	quite	RB	B-ADJP	O
akinetic	akinetic	JJ	I-ADJP	O
and	and	CC	O	O
contrast	contrast	NN	B-NP	O
study	study	NN	I-NP	O
with	with	IN	B-PP	O
stagnant	stagnant	JJ	B-NP	O
flow	flow	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
thrombus	thrombus	NN	B-NP	O
recurrence	recurrence	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
warfarin	warfarin	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
ASA	ASA	NN	B-NP	O
and	and	CC	I-NP	O
plavix	plavix	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
these	these	DT	B-NP	O
three	three	CD	I-NP	O
medications	medication	NNS	I-NP	O
is	be	VBZ	B-VP	O
deferred	defer	VBN	I-VP	O
to	to	TO	I-VP	O
pt	pt	VB	I-VP	O
's	's	POS	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Navejas	Navejas	NNP	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
INR	INR	NN	B-NP	B-protein
drawn	draw	VBN	B-VP	O
locally	locally	RB	B-ADVP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
managed	manage	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
CDMC	CDMC	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
them	them	PRP	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
on	on	IN	B-PP	O
regimen	regimen	NN	B-NP	O
of	of	IN	B-PP	O
lantus	lantus	NN	B-NP	O
,	,	,	O	O
lispro	lispro	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Then	Then	RB	B-NP	O
patient	patient	NN	I-NP	O
acknowledged	acknowledge	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
never	never	RB	I-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

Switched	Switch	VBN	B-VP	O
to	to	TO	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
transferred	transfer	VBN	B-VP	O
on	on	IN	B-PP	O
metformin	metformin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
and	and	CC	B-PP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
until	until	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
*******	*******	SYM	I-NP	O
LABS	LABS	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
6.84	6.84	CD	I-NP	O
;	;	:	O	O
Hct	Hct	NN	B-NP	O
36.8	36.8	CD	I-NP	O
;	;	:	O	O
Platelets	Platelet	NNS	B-NP	O
228	228	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Na	Na	NN	B-NP	O
+	+	SYM	O	O
141	141	CD	B-NP	O
;	;	:	O	O
K	K	NN	B-NP	O
+	+	SYM	B-ADJP	O
4.6	4.6	CD	B-NP	O
;	;	:	O	O
Cl	Cl	NN	B-NP	O
-	-	:	O	O
106	106	CD	B-NP	O
;	;	:	O	O
CO2	CO2	NN	B-NP	O
31	31	CD	I-NP	O
;	;	:	O	O
BUN	BUN	NN	B-NP	O
37	37	CD	I-NP	O
;	;	:	O	O
creatinine	creatinine	NN	B-NP	O
1.0	1.0	CD	I-NP	O
;	;	:	O	O
glucose	glucose	NN	B-NP	O
90	90	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Ca2	Ca2	NN	B-NP	B-protein
+	+	SYM	O	O
9.2	9.2	CD	B-NP	O
;	;	:	O	O
Mg2	Mg2	NN	B-NP	O
+	+	SYM	O	O
2.1	2.1	CD	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.6	1.6	CD	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

HDL	HDL	NN	B-NP	B-protein
48/triglycerides	48/triglyceride	VBZ	B-VP	O
60	60	CD	B-NP	O
During	During	IN	B-PP	O
d/c	d/c	NN	B-NP	O
pt	pt	NN	I-NP	O
questioned	question	VBD	B-VP	O
lasix	lasix	NN	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
reasurred	reasurre	VBN	I-VP	O
dose	dose	NN	B-NP	O
change	change	NN	I-NP	O
to	to	TO	B-VP	O
20mg	20mg	VB	I-VP	O
PO	PO	NN	B-NP	O
qday	qday	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
produced	produce	VBD	B-VP	O
medication	medication	NN	B-NP	O
list	list	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
discharge	discharge	NN	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
stay	stay	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
medications	medication	NNS	B-NP	O
rectified	rectify	VBN	B-VP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
summary	summary	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
without	without	IN	B-PP	O
signing	sign	VBG	B-VP	O
d/c	d/c	NN	B-NP	O
summary	summary	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
in	in	IN	B-PP	O
am	am	NN	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
over	over	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
new	new	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Attending	Attend	VBG	B-VP	O
and	and	CC	O	O
primary	primary	JJ	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
notified	notify	VBN	B-VP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
PLEASE	PLEASE	NN	B-NP	O
CONTACT	CONTACT	NN	I-NP	O
URGENT	URGENT	NN	I-NP	O
CARE	CARE	NN	I-NP	O
ON	ON	NN	I-NP	O
7/3	7/3	CD	I-NP	O
TO	TO	TO	B-PP	O
BE	BE	NNP	B-NP	O
SEEN	SEEN	NNP	I-NP	O
BY	BY	NNP	I-NP	O
1/12	1/12	CD	I-NP	O
FOR	FOR	IN	B-PP	O
BLOOD	BLOOD	NN	B-NP	O
WORK	WORK	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CREATININE	CREATININE	NN	I-NP	O
AND	AND	CC	I-NP	O
ELECTROLYTE	ELECTROLYTE	NN	I-NP	O
CHECK	CHECK	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

CALL	CALL	NN	B-NP	B-protein
AT	AT	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
224	224	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
540-6772	540-6772	CD	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
increasing	increase	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
or	or	CC	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
please	please	NN	B-NP	O
seek	seek	VBP	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
again	again	RB	B-ADVP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
measure	measure	NN	I-NP	O
and	and	CC	O	O
record	record	NN	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
increases	increase	NNS	B-NP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
3	3	CD	I-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Agner	Agner	NNP	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
rehab	rehab	NN	I-NP	O
.	.	.	O	O

as	as	IN	B-PP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Titrate	Titrate	NNP	I-NP	O
lasix	lasix	NN	I-NP	O
as	as	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Check	Check	NNP	I-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SOUKUP	SOUKUP	NN	B-NP	O
,	,	,	O	O
MARKUS	MARKUS	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LW26	LW26	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/5/06	2/5/06	CD	I-NP	O
@	@	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
52	52	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

